lobbying_activities: 2457844

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2457844	856202ad-ea42-4991-ae59-0d36df45b650	2T	THE NICKLES GROUP, LLC	293335	EDITAS MEDICINE	2020	second_quarter	MMM	Issues related to reimbursement of novel therapies; monitored issue related to drug pricing; S. 2543, Prescription Drug Pricing Reduction Act of 2019.	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	10000		0	1	2020-05-06T10:49:37.840000-04:00